Insider Monkey41d agoneutral
Amgen (AMGN) Has a New Growth Opportunity. But How Much Is It Really Worth?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey41d agoneutral
Can Roche’s Latest Obesity Drug Results Help it Challenge Eli Lilly and Novo Nordisk?Insider Monkey42d agobearish
Amgen (AMGN) Sells its Deerfield Campus for $151 Million and Leases it BackMotley Fool43d agoneutral
2 Healthcare Stocks That Just Delivered Great News for InvestorsThe Real Deal44d agoneutral
Amgen’s Deerfield office campus sold to Mesirow for $151M in sale-leaseback dealSimply Wall St.44d agoneutral
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma ClientsStockStory45d agoneutral
Winners And Losers Of Q2: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics StocksSimply Wall St.46d agoneutral
Amgen (AMGN) Is Up 7.9% After Positive Phase 3 Dazodalibep Data in Systemic Sjögren’s DiseaseProactive46d agoneutral
Amgen price target raised by Jefferies to $410 after positive Sjögren's dataMT Newswires47d agoneutral
Update: US Equity Indexes Close Mixed While Treasury Yields Retreat With Crude OilStocktwits47d agobullish
AMGN Jumps After Win In Sjögren’s Disease Trial As Citi Flags ‘Open Questions’MT Newswires47d agoneutral
Update: US Equity Indexes, Crude Oil Prices Mixed in Midday Trading